AAAAAA
Results:
1-14
|
Results: 14
Authors:
Laqueille, X
Poirier, MF
Jalfre, V
Bourdel, MC
Willard, D
Olie, JP
Citation: X. Laqueille et al., Factors predicting the response to buprenorphine in substitutive therapy of heroin addicts - Results of a multicenter study of 73 patients, PRESSE MED, 30(32), 2001, pp. 1581-1585
Authors:
Gut-Fayand, A
Dervaux, A
Olie, JP
Loo, H
Poirier, MF
Krebs, MO
Citation: A. Gut-fayand et al., Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity, PSYCHIAT R, 102(1), 2001, pp. 65-72
Authors:
Leroy, S
Griffon, N
Bourdel, MC
Olie, JP
Poirier, MF
Krebs, MO
Citation: S. Leroy et al., Schizophrenia and the cannabinoid receptor type 1 (CB1): Association studyusing a single-base polymorphism in coding exon 1, AM J MED G, 105(8), 2001, pp. 749-752
Authors:
Dervaux, A
Bayle, FJ
Laqueille, X
Bourdel, MC
Le Borgne, MH
Olie, JP
Krebs, MO
Citation: A. Dervaux et al., Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?, AM J PSYCHI, 158(3), 2001, pp. 492-494
Authors:
Krebs, MO
Guillin, O
Bourdel, MC
Schwartz, JC
Olie, JP
Poirier, MF
Sokoloff, P
Citation: Mo. Krebs et al., Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia, MOL PSYCHI, 5(5), 2000, pp. 558-562
Authors:
Ito, C
Morisset, S
Krebs, MO
Olie, JP
Loo, H
Poirier, MF
Lannfelt, L
Schwartz, JC
Arrang, JM
Citation: C. Ito et al., Histamine H-2 receptor gene variants: lack of association with schizophrenia, MOL PSYCHI, 5(2), 2000, pp. 159-164
Authors:
Krebs, MO
Gut-Fayand, A
Bourdel, MC
Dischamp, J
Olie, JP
Citation: Mo. Krebs et al., Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia, SCHIZOPHR R, 45(3), 2000, pp. 245-260
Authors:
Galinowski, A
Castelnau, C
Spreux-Varoquaux, O
Bourdel, MC
Olie, JP
Loo, H
Poirier, MF
Citation: A. Galinowski et al., Evolution of Plasma Homovanillic Acid (HVA) levels during treatment in schizo-affective disorder, PROG NEUR-P, 24(8), 2000, pp. 1319-1328
Authors:
Bayle, FJ
Llorca, PM
Olie, JP
Loo, H
Citation: Fj. Bayle et al., Anxiety and schizophrenia: review of research, ANN MED PSY, 158(10), 2000, pp. 741-749
Authors:
Millet, B
Borontain, S
Olie, JP
Citation: B. Millet et al., Cardiac risk at the onset of a treatment combining benzodiazepines and clozapine: report on two cases, ANN MED PSY, 158(10), 2000, pp. 805-806
Authors:
Millet, B
Touitou, Y
Poirier, MF
Bourdel, MC
Amado, I
Hantouche, EG
Bogdan, A
Olie, JP
Citation: B. Millet et al., Obsessive-compulsive disorder: evaluation of clinical and biological circadian parameters during fluoxetine treatment, PSYCHOPHAR, 146(3), 1999, pp. 268-274
Authors:
Krebs, MO
Olie, JP
Citation: Mo. Krebs et Jp. Olie, Tardive dystonia induced by risperidone, CAN J PSY, 44(5), 1999, pp. 507-508
Authors:
Vanelle, JM
Olie, JP
Citation: Jm. Vanelle et Jp. Olie, Providing information to schizophrenic patients and their concerned othersregarding their biological treatments, ANN MED PSY, 157(7), 1999, pp. 491-499
Authors:
Loo, H
Olie, JP
Citation: H. Loo et Jp. Olie, In memory of Pierre Deniker (1917-1998), EVOL PSYCH, 63(4), 1998, pp. 701-702
Risultati:
1-14
|